From the Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, China.
Arch Pathol Lab Med. 2014 Jan;138(1):114-20. doi: 10.5858/arpa.2012-0526-OA.
The first-class hospital laboratories are required to participate in a proficiency testing (PT) program by the Ministry of Health of the People's Republic of China. The College of American Pathologists (CAP) PT programs have increasingly become laboratories' preferred choices because of the well-prepared specimens, more comprehensive programs, scientific evaluation, and useful educational opportunities involved.
To evaluate the PT performance of our laboratory from 2007 to 2011 through the selected analytes and tests.
The PT results of 22 commonly performed tests in 15 events were evaluated. The rates of unacceptable results for all analytes and tests during the 5-year study period were compared with χ (2) test. Reasons for all unacceptable results were sorted into 8 groups.
A total of 13 of 22 analytes and tests (59.1%) achieved full scores (100%), whereas 6 analytes and tests failed to reach the goal of getting a score of 80% or higher in PT. Seen from the relative distance of the results from the target as a percentage of allowed deviation, the performance of some analytes was excellent, including albumin, amylase, lactate dehydrogenase, potassium, protein, total, uric acid, red blood cell, white blood cell, and hemoglobin. Rates of unacceptable results for all analytes demonstrated a trend of decline. The top 3 reasons for unacceptable results were identification errors in morphologic tests, specimen problems, and technical problems (25.74%, 23.76%, and 14.85%, respectively).
The PT performance demonstrated a trend of improvement from 2007 to 2011. Proficiency testing contributed to the improvement of laboratory performance, especially the promotion of better patient care.
中国卫生部要求一流医院实验室参加能力验证(PT)计划。由于准备充分的标本、更全面的计划、科学的评估和有益的教育机会,美国病理学家学会(CAP)的 PT 计划越来越成为实验室的首选。
通过选择的分析物和测试,评估我们实验室从 2007 年到 2011 年的 PT 性能。
评估了 15 项活动中的 22 项常见测试的 PT 结果。比较了 5 年研究期间所有分析物和测试的不可接受结果率与 χ (2)检验。将所有不可接受结果的原因分为 8 组。
共有 22 项分析物和测试中的 13 项(59.1%)获得满分(100%),而 6 项分析物和测试未能达到 PT 获得 80%或更高分数的目标。从结果与允许偏差百分比的相对距离来看,某些分析物的性能非常出色,包括白蛋白、淀粉酶、乳酸脱氢酶、钾、蛋白、总蛋白、尿酸、红细胞、白细胞和血红蛋白。所有分析物不可接受结果的比率呈下降趋势。不可接受结果的前 3 个原因是形态学测试中的识别错误、标本问题和技术问题(分别占 25.74%、23.76%和 14.85%)。
从 2007 年到 2011 年,PT 性能呈上升趋势。能力验证有助于提高实验室的性能,特别是促进更好的患者护理。